Oasis Capital was named "China's Most LP-Recognized Early-Stage Investment Firm of 2022" by 36Kr.
36Kr released its 2022 annual series of rankings today. 36Kr's LP-GP survey has now been held for four consecutive editions, dedicated to identifying and spotlighting investment institutions and their limited partners that merit attention in the market.
36Kr released its 2022 annual rankings today. 36Kr's LP-GP survey is now in its fourth edition, dedicated to identifying the investment firms and their backers most worth watching in the market.
Since its launch, 36Kr's research institute has invited 1,500+ VC, PE, fund-of-funds, and corporate investors to participate. It distributed targeted questionnaires to collect detailed data across four dimensions — fundraising, investing, portfolio management, and exits — then conducted follow-up site visits and phone interviews based on survey responses to understand the full market picture before finalizing the rankings.
Among the results, Oasis Capital was named to the 2022 "Top 50 Early-Stage Investment Firms Most Recognized by LPs in China."
The world changes endlessly, noise overloads. Oasis Capital will continue to uphold a "top-down" research approach, combining the experience of ecosystem entrepreneurs to consistently signal long-term value for companies.
We remain anchored by "demographics" and "technology innovation" as our entry points, focusing on technology-enabled sectors including healthcare and enterprise services, and making long-term bets on the most vital entrepreneurs. Celebrating Vitality.
Click "Read More" to view the full rankings.
Oasis Capital is a new-generation venture capital firm in China, dedicated to discovering the most vital entrepreneurs of the coming decade and growing alongside them to create long-term value. "Celebrating Vitality" is Oasis's vision and mission. This vitality is both the direction of structural transformation in our times and the resilience and evolutionary force of entrepreneurs themselves. Oasis Capital focuses on early and growth-stage investments, writing checks of $3 million to $30 million, with particular emphasis on technology-enabled services in healthcare, enterprise software, and related fields — supporting China's new service upgrade driven by technology.
